Screener
Recursion Pharmaceuticals, Inc. RXRX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity | ||
| Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of June 30, 2026 and December 31, 2025; 534,120,235 shares (Class A 533,191,318, Class B — and Exchangeable 928,917) and 528,182,693 shares (Class A 521,831,046, Class B 5,547,334 and Exchangeable 804,313) issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 5 | 5 |
| Additional paid-in capital | 3,211,515 | 3,170,145 |
| Accumulated deficit | (2,324,511) | (2,076,002) |
| Accumulated other comprehensive income | 27,994 | 36,717 |
| Total stockholders’ equity | 915,003 | 1,130,865 |
| Total liabilities and stockholders’ equity | $1,212,668 | $1,474,130 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s total equity?
- Recursion Pharmaceuticals, Inc. (RXRX) reported total equity of $915M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s total equity decreased by 0.5% year-over-year, from $919.15M to $915M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s total equity has grown at a 40.5% compound annual growth rate (CAGR), from -$206.29M to $1.13B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Recursion Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude